Drug Giants Commit To $100M Dementia Research VC Fund
Leading drugmakers GlaxoSmithKline PLC, Eli Lilly & Co., Pfizer Inc. and others have joined the U.K. government in investing in a $100 million venture capital fund aimed at researching the prevention...To view the full article, register now.
Already a subscriber? Click here to view full article